Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allovir Inc ALVR

Healthcare Biotechnology
AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life... see more

Recent & Breaking News (NDAQ:ALVR)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR

Accesswire February 8, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire February 8, 2024

Class Action Filed Against AlloVir, Inc. (ALVR) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire February 7, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVR

PR Newswire February 7, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 7, 2024

AlloVir Shareholder Notice

Newsfile February 7, 2024

INVESTOR ALERT: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

Accesswire February 7, 2024

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Accesswire February 7, 2024

SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

Accesswire February 7, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire February 7, 2024

INVESTOR ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALVR

Accesswire February 6, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Newsfile February 6, 2024

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm

Accesswire February 6, 2024

INVESTOR ALERT: Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR

Accesswire February 6, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Notifies AlloVir, Inc.(ALVR) Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire February 6, 2024

SHAREHOLDER ALERT: Levi & Korsinsky Reminds AlloVir, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVR

Accesswire February 6, 2024

SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

Accesswire February 6, 2024

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AlloVir Inc. Investors Can Join the Class Action Lawsuit!

Accesswire February 6, 2024

ALVR Stock News: Investors with Large Losses Should Contact Robbins LLP for Information About the Class Action Against AlloVir, Inc.

Business Wire February 6, 2024

ROSEN, NATIONAL TRIAL LAWYERS, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR

Newsfile February 5, 2024